Quantum Pharma PLC Notification of Major Interest in Shares (1383P)
15 November 2016 - 3:20AM
UK Regulatory
TIDMQP. TIDMAV.
RNS Number : 1383P
Quantum Pharma PLC
14 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Quantum Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached:
--------------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------------------------
Other (please CHANGE TO THE NUMBER OF VOTING RIGHTS
specify): IN ISSUE, FOLLOWING THE RECENT PLACING.
----------------------------------------------------------- ---------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
------------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):
BNY Norwich Union Nominees
Limited 282,753*
Chase (GA Group) Nominees
Limited 6,402,583*
State Street Nominees Limited
1,232,291*
*denotes direct interest
Chase Nominees Limited 203,374
------------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 11 November 2016
and date on
which the threshold is
crossed or
reached:
------------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 14 November 2016
notified:
------------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are 6% to 4% Change at Direct
crossed or Interest Level
reached: >5% to <5% Change at Combined
Interest Level
------------------------------------------------------------- ---------------------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-----------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------- ------------------------------- -----------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights
Shares Voting shares rights
Rights
------------------- ------------------- ---------- ---------- --------------------- ------------------
Direct Direct Indirect Direct Indirect
------------------- ------------------- ---------- ---------- ---------- --------- ------- ---------
Ordinary
Shares
GB00BRTL8Q42 8,910,561 8,910,561 8,121,001 7,917,627 203,374 4.68% 0.12%
------------------- ---------- ---------- ---------- --------- ------- ---------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
Period may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------------- ---------------------- --------------------- ------------------
297,000*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct interest 0.18%
------------------- ------------------- ---------------------- --------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights
period refers to
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,418,001 4.98%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
------------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- -------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
--------------------------------------------- -------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
--------------------------------------------- -------------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
169,117,640 as per the Company's
'Result of General Meeting
& Total Voting Rights' announcement
of 10 November 2016.
--------------------------------------------- -------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
--------------------------------------------- -------------------------------------
15. Contact telephone number: 01603 684420
--------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGQGGUPQGQC
(END) Dow Jones Newswires
November 14, 2016 11:20 ET (16:20 GMT)
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Apr 2024 to May 2024
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Quantum Phar. (London Stock Exchange): 0 recent articles
More Quantum Phar. News Articles